Zoetis (ZTS) director awarded 1,964 restricted stock units vesting in 2025

Rhea-AI Filing Summary

Zoetis Inc.$127.25 per unit.

Each RSU represents a contingent right to receive one share of Zoetis common stock. The RSUs are scheduled to vest and be settled in Zoetis common shares on the first anniversary of the grant date, December 1, 2025, provided the director continues to serve through that date, with potential earlier vesting upon certain specified events.

12/02/2025 - 04:28 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tilenius Stephanie

(Last) (First) (Middle)

C/O ZOETIS INC.

10 SYLVAN WAY

(Street)

PARSIPPANY NJ 07054

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit(1)	(2)	12/01/2025		A		1,964		(3)	(4)	Common Stock	1,964	$127.25	1,964	D

Explanation of Responses:

1. Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

2. Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

3. Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, December 1, 2025, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

4. Not applicable.

Remarks:

	/s/ Brenda Santuccio, as Attorney-in-Fact	12/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Zoetis (ZTS) report in this Form 4?

Zoetis reported that a director received 1,964 restricted stock units (RSUs) on 12/01/2025 under the company’s Amended and Restated 2013 Equity and Incentive Plan.

How many Zoetis (ZTS) RSUs were granted to the director?

The director was granted 1,964 RSUs, each representing a contingent right to receive one share of Zoetis Inc. common stock.

When do the Zoetis (ZTS) RSUs granted on 12/01/2025 vest?

Each RSU will vest and be settled in Zoetis common stock on the first anniversary of the grant date, December 1, 2025, subject to continued service and certain specified events.

What does each Zoetis (ZTS) RSU represent in this Form 4?

Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock upon vesting and settlement.

Under which plan were the Zoetis (ZTS) RSUs granted to the director?

The RSUs were granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, including dividend equivalent units issued on the RSUs.

What is the exercise price of the Zoetis (ZTS) RSUs reported?

The RSUs are shown with an exercise or conversion price of $127.25 per unit.